Substance abuse and the kidney

QJM: An International Journal of Medicine

Volumn 93, Issue 3, 2000, Pages 147-152

  Crowe, A V ^a   Howse, M ^a   Bell, G M ^a   Henry, J A ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; BENZODIAZEPINE; CANNABIS; COCAINE; DIAMORPHINE; DIAZEPAM; PSYCHEDELIC AGENT; SOLVENT; TEMAZEPAM;

HUMAN; KIDNEY; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE; TOBACCO;

EID: 0034052086     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/93.3.147     Document Type: Review

References (63)

1. Strang J. Substance Abuse: The Size of the Problem. Medicine 1995; 23:41-5.
2. Institute for the Study of Drug Dependence. General statistical information about drugs. November 1997.
3. Gunne LM, Gronbladh L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Dependence 1981; 24:249-56.
4. Gerada C, Ashworth M. ABC of mental health: Addiction and dependence I: Illicit drugs. Br Med J 1997; 315:297-300.
5. Sreepada Rao TKS, Nicastri AD, Friedman EA. Renal consequences of narcotic abuse. Adv Nephrol 1977; 7:261-90.
6. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974; 291:807-11.
7. Tuazon CU, Hill R, Sheagren JN. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis 1974; 129:327-9.
8. Roberts WC, Rabson AS. Focal glomerular lesions in fungal endocarditis. Ann Int Med 1975; 71:963-70.
9. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS. Amyloidosis and subcutaneous heroin abusers ('skin poppers' amyloidosis'). Am J Med 1986; 81:635-40.
10. Crowley S, Feinfeld DA, Janis R. Resolution of nephrotic syndrome and lack of heroin-associated renal amyloidosis. Am J Kid Dis 1989; 13:333-5.
11. Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC. Heroin nephropathy. A clinicopathologic and epidemiologic study. Am J Med 1980; 68:47-53.
12. Friedman EA, Tao TK. Disappearance of uremia due to heroin-associated nephropathy. Am J Kid Dis 1995; 25:689-93.
13. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: A detailed morpholgic and comparative study. Kidney Int 1989; 35:1358-70.
14. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338:1428-37.
15. Humphreys MH. Human immunodeficency virus-associated glomerulosclerosis. Kid Int 1995; 48:311-20.
16. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352:783-4.
17. Dettmeyer R, Wessling B, Madea B. Heroin associated nephropathy - a post-mortem study Forensic Sci Int 1998; 95:109-16.
18. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 1993; 72:3-12.
19. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgiognie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 1988; 319:673-7.
20. Welch RD, Todd K, Krause GS. Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med 1991; 20:154-7.
21. Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med 1984; 13:1145-7.
22. Fogo A, Superdock KR, Atkinson JB. Severe arteriosclerosis in the kidney of a cocaine addict. Am J Kid Dis 1992; 20:513-15.
23. Di Paolo N, Fineschi V, Di Paolo M, Wetley CV, Del Vecchio MT, Bianciardi G. Kidney vascular damage and cocaine. Clin Nephrol 1997; 47:298-303.
24. Thornhill-Joynes M, Norris KC, Witana SC, Ward HJ, Barbour B. The impact of substance abuse on hypertensive end-stage renal disease in inner city African-Americans. J Am Soc Nephrol 1994; 5:342.
25. Brecklin CS, Gopaniuk-Folga A, Kravetz T, Sabah S, Singh A, Arruda JAL, Dunea G. Prevalence of hypertension in chronic cocaine users. A J Hypertension 1998; 11:1279-83.
26. Dunea G, Arruda JA, Bakir AA, Share DS, Smith EC. Role of cocaine in end-stage renal disease in some hypertensive African-Americans. Am J Nephrol 1995; 15:5-9.
27. Mattana J, Gibbons N, Singhal PC. Cocaine interacts with macrophages to modulate mesangial cell proliferation. J Pharmacol Exp Ther 1994; 271:311-18.
28. Lam M, Ballou SP. Reversible scleroderma renal crisis after cocaine use. N Engl J Med 1992; 326:1435.
29. Chevalier X, Rostoker G, Larget-Piet B, Gherardi R. Schoenlain-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 1995; 43:348-9.
30. Verebey K, Alrazi J, Depace A. The complications of 'Ecstasy' (MDMA). JAMA 1988; 259:1649-50.
31. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 1992; 340:384-7.
32. Fahal IH, Sallomi DF, Yaqoob M, Bell GM. Acute renal failure after ecstasy. Br Med J 1992; 305:29.
33. Maxwell DL, Polkey MI, Henry JA. Hyponatraemia and catatonic stupor after taking 'ecstasy'. Br Med J 1993; 307:1399.
34. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M. Low-dose MDMA ('ecstasy') induces vasopressin secretion. Lancet 1998; 351:1784.
35. Dowling GP, McDonough ET, Bost RO. 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987; 257:1615-17.
36. Woodrow G, Harnden P, Turney JH. Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant 1995; 10:399-400.
37. Bryden AA, Rothwell PJ, O'Reilly PH. Urinary retention with misuse of 'ecstasy'. Br Med J 1995; 310:504.
38. Lavelle TL, Hammersley R, Forsyth A. The use of buprenorphine and temazepam by drug injectors. J Addict Dis 1991; 10:5-14.
39. Blair SD, Holcombe C, Coombes EN, O'Malley MK. Leg ischaemia secondary to non-medical injection of temazepam. Lancet 1991; 338:1393-4.
40. Jenkinson DF, Pusey CD. Rhabdomyolysis and renal failure after intra-arterial temazepam. Nephrol Dial Transplant 1994; 9:1334-5.
41. Proudfoot AT. Acute Poisoning, 2nd edn. Butterworth-Heinneman, 1993:145-60.
42. Richard JM, Louis J, Cantin D. Nephrotoxicity of orellanine, a toxin from the mushroom Cortinarius orellanus. Arch Toxicol 1988; 62:242-5.
43. Raff E, Halloran F, Kjellstrand CM. Renal failure after eating 'magic' mushrooms. Can Med Assoc J 1992; 147:1339-41.
44. Short AK, Watling R, MacDonald MK, Robson JS. Poisoning by Cortinarius speciosissmus. Lancet 1980; 2:942-4.
45. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int 1997; 51:1669-77.
46. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Med 1992; 152:2082-8.
47. Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kid Int 1995; 48:171-6.
48. Herody M, Bobrie G, Gouarin C, Grunfeld JP, Noel LH. Anti-GBM disease: Predictive value of clinical, histological and serological data. Clin Neph 1993; 40:249-55.
49. Hultberg B, Isaksson A, Brattstrom L, Israelsson B. Elevated urinary excertion of beta-hexosaminidase in smokers. Eur J Clin Chem Clin Biochem 1992; 30:131-3.
50. Lambrecht GL, Malbrain ML, Coremans P, Verbist L, Verhaegen H. Acute renal infarction and heavy marijuana smoking. Nephron 1995; 70:494-6.
51. Ramsey JD, Anderson HR, Bloor K, Flanagan RJ. An introduction to the practice, prevalence, and chemical toxicology of volatile substance abuse. Hum Toxicol 1989; 8:261-9.
52. Bruckner JV, Peterson RG. Evaluation of toluene and acetone inhalant abuse: pharmacology and pharmacodyamics. Toxicol Appl Pharmacol 1981; 61:27-38.
53. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J 1996; 89:455-62.
54. Patel R, Benjamin J Jr. Renal disease associated with toluene inhalation. J Toxicol Clin Toxicol 1986; 24:213-23.
55. Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD. Syndromes of toluene sniffing in adults. Ann Intern Med 1981; 94:758-62.
56. Kaneko T, Koizumi T, Takezaki T, Sato A. Urinary calculi associated with solvent abuse. J Urol 1992; 147:1365-6.
57. Venkataraman G. Renal damage and glue sniffing. Br Med J 1981; 283:1467.
58. Bonzel KE, Muller-Wiefel DE, Ruder H, Wingen AM, Waldherr R, Weber M. Anti-glomerular basement membrane antibody-mediated glomerulonephritis due to glue sniffing. Eur J Paediatr 1987; 146:296-300.
59. Gupta RK, van der Meulen J, Johny KV. Oliguric acute renal failure due to glue-sniffing. Scand J Urol Nephrol 1991; 25:247-50.
60. O'Brien ET, Yeoman WB, Hobby JA. Hepatorenal damage from toluene in a 'glue sniffer'. Br Med J 1971; 2:29-30.
61. Taverner D, Harrison DJ, Bell GM. Acute renal failure due to intersitital nephritis induced by 'glue sniffing' with subsequent recovery. Scot Med J 1988; 33:246-7.
62. Russ G, Clarkson AR, Woodroffe AJ, Seymour AE, Cheng IK. Renal failure from 'glue sniffing'. Med J Aust 1981; 2:121-2.
63. Newell GC. Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 1987; 9:183-90.